- Home
- BDL vs FBIO Comparison
BDL vs FBIO Comparison
Compare BDL & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDL
- FBIO
- Stock Information
- Founded
- BDL 1959
- FBIO 2006
- Country
- BDL United States
- FBIO United States
- Employees
- BDL N/A
- FBIO N/A
- Industry
- BDL Restaurants
- FBIO Biotechnology: Pharmaceutical Preparations
- Sector
- BDL Consumer Discretionary
- FBIO Health Care
- Exchange
- BDL Nasdaq
- FBIO Nasdaq
- Market Cap
- BDL 61.8M
- FBIO 53.5M
- IPO Year
- BDL N/A
- FBIO N/A
- Fundamental
- Price
- BDL $31.02
- FBIO $1.91
- Analyst Decision
- BDL
- FBIO Strong Buy
- Analyst Count
- BDL 0
- FBIO 2
- Target Price
- BDL N/A
- FBIO $21.00
- AVG Volume (30 Days)
- BDL 983.0
- FBIO 182.1K
- Earning Date
- BDL 08-19-2025
- FBIO 08-12-2025
- Dividend Yield
- BDL 1.61%
- FBIO N/A
- EPS Growth
- BDL 14.76
- FBIO N/A
- EPS
- BDL 2.18
- FBIO N/A
- Revenue
- BDL $198,785,000.00
- FBIO $57,784,000.00
- Revenue This Year
- BDL N/A
- FBIO $51.59
- Revenue Next Year
- BDL N/A
- FBIO $44.74
- P/E Ratio
- BDL $14.24
- FBIO N/A
- Revenue Growth
- BDL 9.31
- FBIO N/A
- 52 Week Low
- BDL $22.61
- FBIO $1.33
- 52 Week High
- BDL $35.98
- FBIO $2.36
- Technical
- Relative Strength Index (RSI)
- BDL 46.03
- FBIO 50.82
- Support Level
- BDL $30.40
- FBIO $1.77
- Resistance Level
- BDL $34.49
- FBIO $2.02
- Average True Range (ATR)
- BDL 0.60
- FBIO 0.09
- MACD
- BDL -0.41
- FBIO -0.01
- Stochastic Oscillator
- BDL 15.12
- FBIO 51.92
About BDL Flanigan's Enterprises Inc.
Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.